Skip to main content
. 2020 Apr 10;18(7):1561–1566. doi: 10.1016/j.cgh.2020.04.002

Table 1.

Clinical Characteristics of 148 Patients Infected With SARS-CoV-2

All (148) Liver function
P value
Abnormal (55) Normal (93)
Age 50 (36 –64) 52 (37–65) 50 (36–63) .5829
Sex, n (%)
Female 75 (50.7) 14 (25.5) 61 (65.6) < .0001
Male 73 (49.3) 41 (74.5) 32 (34.4)
Signs and symptoms at admission, n (%)
 Fever 127 (85.8) 48 (87.3) 79 (84.9) .6951
 Cough 67 (45.3) 25 (45.5) 42 (45.2) .9724
 Expectoration 38 (26.7) 14 (25.5) 24 (25.8) .9622
 Diarrhea 6 (4.1) 1 (1.8) 5 (5.4) .4124
 Nausea and vomiting 3 (2.0) 1 (1.8) 2 (2.2) 1
 Asymptomatic 5 (3.4) 2 (3.6) 3 (3.2) 1
 With other liver diseases 9 (6.1) 4 (7.3) 5 (5.4) .6409
Temperature (°C), n (%)
 ≤37.2 21 (14.2) 7 (12.7) 14 (15.1) .6951
 37.3–38 70 (47.3) 24 (43.6) 46 (49.5) .4927
 38.1–39 45 (30.4) 16 (29.1) 29 (31.2) .7892
 ≥39.1 12 (8.1) 8 (14.5) 4 (4.3) .0274
 Onset of symptom to admission, d 5 (3–7) 5 (3–8) 5 (3–7) .32
Laboratory examination, median (interquartile range)
 WBC (∗10ˆ9/L) 4.635 (3.62–5.7) 5.04 (3.89–5.72) 4.35 (3.55–5.6) .1033
 Lymphocytes 1.115 (0.76–1.51) 1.05 (0.69–1.57) 1.2 (0.785,1.5) .3208
 PCT 0.03 (0.02–0.06) 0.06 (0.03–0.09) 0.02 (0.02–0.05) < .0001
 CRP 17.75 (8.7–32.38) 25 (12.68–42.18) 13.2 (7.9–25.83) .0105
 ESR 50 (32–84) 70 (36–86) 47.5 (31.25–83.5) .4181
 CD4+ T, cell/μL 407 (261–619.8) 397 (216–591) 408 (290–628) .3
 CD8+ T, cell/μL 260 (163.3–384.5) 225 (148–364) 265 (181.5–403) .1227
 CD3+ T, cell/μL 710 (494.5–1024) 638 (424–1056) 752 (546–1024) .2066
 LDH 224.5 (193–283.8) 257 (227–369) 207 (186–243) < .0001
Clinical outcomes, n (%)
 Severe/critically ill 10 (6.8) 5 (9.1) 5 (5.4) .3843
 Cured and discharged 92 (62.2) 34 (62.8) 58 (62.4) .9471
 Death 1 (0.7) 1 (1.8) 0 .3716

CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase; PCT, procalcitonin; WBC, white blood cell count.